These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34321240)

  • 1. Mutant
    Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
    Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL).
    Negi V; Aplan PD
    Oncoscience; 2022; 9():60-63. PubMed ID: 36330381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.
    Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
    Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.
    Choi CW; Chung YJ; Slape C; Aplan PD
    J Immunol; 2009 Nov; 183(10):6227-35. PubMed ID: 19841179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
    Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
    Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
    Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
    Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells.
    Chen J; Yang J; Wei Q; Weng L; Wu F; Shi Y; Cheng X; Cai X; Hu C; Cao P
    Cell Commun Signal; 2020 Apr; 18(1):55. PubMed ID: 32245484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.
    Kats LM; Reschke M; Taulli R; Pozdnyakova O; Burgess K; Bhargava P; Straley K; Karnik R; Meissner A; Small D; Su SM; Yen K; Zhang J; Pandolfi PP
    Cell Stem Cell; 2014 Mar; 14(3):329-41. PubMed ID: 24440599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants.
    Gao M; Zhu H; Fu L; Li Y; Bao X; Fu H; Quan H; Wang L; Lou L
    Cancer Sci; 2019 Oct; 110(10):3306-3314. PubMed ID: 31361380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the NUP98-CCDC28A fusion protein.
    Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
    Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
    Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
    Lu J; Chen M; Hua H; Qin W; Zhang R; Lu X; Chao H
    Int J Lab Hematol; 2021 Dec; 43(6):1483-1490. PubMed ID: 34270876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
    Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
    Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
    Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
    Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic IDH2
    Wang D; Zheng L; Cheng BYL; Sin CF; Li R; Tsui SP; Yi X; Ma ACH; He BL; Leung AYH; Sun X
    Oncogene; 2023 Apr; 42(16):1272-1281. PubMed ID: 36739363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL.
    Slape C; Chung YJ; Soloway PD; Tessarollo L; Aplan PD
    Leukemia; 2007 Jun; 21(6):1239-48. PubMed ID: 17377591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
    Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
    J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
    Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
    J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.
    Greenblatt S; Li L; Slape C; Nguyen B; Novak R; Duffield A; Huso D; Desiderio S; Borowitz MJ; Aplan P; Small D
    Blood; 2012 Mar; 119(12):2883-94. PubMed ID: 22323452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.